Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |